Today, we are already helping millions of people worldwide live longer, healthier lives. But our ultimate goal is to create social impact for the entire population – capable of serving every patient. To achieve this, we address health equity and wellbeing across the whole patient continuum of care: from pharmaceutical innovation over prevention and healthcare delivery to tackling equitable access.
We focus on rapid innovation, integrating sustainability along our entire value chain and fostering multi-stakeholder collaboration. In particular to improve the lives of people and animals living in underserved communities.
- MORE HEALTH: Expanding access to healthcare for 50 million people in underserved communities, investing 35 billion EUR in health innovation and research to tackle non-communicable diseases and an additional 250 million EUR in partnerships to combat emerging infectious diseases.
- MORE POTENTIAL: Our aim is to positively impact 50 million people in underserved communities by empowering and supporting our employees, partners, and innovative social entrepreneurs.
- MORE GREEN: We will become carbon-neutral in our company operations by 2030 (Scope 1 and 2). We will also significantly reduce the resource footprint across the value chain in the same period, despite our growing business activities.